CYTONICS
Cytonics engages in PC-controlled micropattern light irradiation device and photoresponsive cell culture dish. It was established on 2007 Decembers 12.
CYTONICS
Industry:
Health Care Medical Medical Device
Founded:
2007-12-12
Address:
Matsumoto, Nagano, Japan
Country:
Japan
Website Url:
http://www.cytonics.jp
Status:
Closed
Similar Organizations
Apsun
Apsun engages in rehabilitation medical devices and products.
Taryag Medical
Taryag Medical is a medical device company that develops and manufactures invasive vascular devices.
Current Employees Featured
More informations about "Cytonics"
Management - Cytonics Corporation
Cytonics has received over $25M in funding to date, including $1.8M from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). Now, we are raising capital from both non-accredited and …See details»
Home - New - Cytonics Corporation
Cytonics has received over $15M in funding to-date, including $1.8M in grants from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). …See details»
Cytonics Corporation | LinkedIn
Cytonics Corporation | LinkedInのフォロワー数684人。Relief For Osteoarthritis! | Cytonics is a research and development company dedicated to discovering and developing therapeutics …See details»
Cytonics - Crunchbase Company Profile & Funding
Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan Complex Test (FACT) for molecular discography and FACT Plus multi analyte assay for …See details»
Cytonics - Crunchbase Company Profile & Funding
Cytonics engages in PC-controlled micropattern light irradiation device and photoresponsive cell culture dish. It was established on 2007 Decembers 12. Lists Featuring This CompanySee details»
About - Cytonics Corporation
Cytonics is a privately held biotechnology company specializing in the development of diagnostics and therapeutics for osteoarthritis (OA), a disease of the joints that renders the afflicted …See details»
Cytonics Company Profile 2024: Valuation, Funding
JP-2021080282-A: Therapeutic variant alpha-2-macroglobulin compositions: Active: 20-Nov-2014: C07K14/811: To view Cytonics’s complete patent history, request access » ... Synartro, EpiBone, The Binding Site, and Ampio …See details»
Cytonics - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cytonics with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
#28 The Business of Biotech (4th ... - Cytonics …
May 1, 2024 The CEO of Cytonics, Joey Bose, navigates a day filled with challenges in spearheading the company’s mission. From managing emails and operations to engaging in international collaboration and physical activities, his …See details»
#6 Meet The Cytonics Triumvirate - Cytonics Corporation
Jan 2, 2024 In the competitive world of biopharmaceutical R&D, Cytonics is taking on Big Pharma in the fight against osteoarthritis. Led by Dr. Gaetano Scuderi, Joey Bose, and Dr. Lewis Hanna, they bring a unique blend of clinical …See details»
FAQ - Cytonics Corporation
Cytonics has received over $25M in funding to date, including $1.8M from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). Now, we are …See details»
Cytonics - Funding, Financials, Valuation & Investors - Crunchbase
Cytonics is a biotechnology company developing diagnostic assays focusing on musculoskeletal-related pain. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much funding …See details»
#9 Cytonics’ End of Year Missive by Joey Bose, CEO
Jan 3, 2024 Cytonics had a successful 2023, with strong market support and investments. The outlook for 2024 is positive, predicting increased M&A activity, IPOs, and venture capital …See details»
Cytonics (@cytonics_corporation) • Instagram photos and videos
1,744 Followers, 15 Following, 101 Posts - Cytonics (@cytonics_corporation) on Instagram: "Cytonics is a ... . 🔹 Received regulatory approval to begin the first-in-human Phase 1 clinical …See details»
Cytonics Co., Ltd. - Products, Competitors, Financials, Employees ...
Provider of cell engineering services. Use the CB Insights Platform to explore Cytonics Co., Ltd.'s full profile.See details»
Cytonics Corporation – In this blog series, we will illuminate …
Dec 11, 2024 Cytonics Corporation’s Phase 1 clinical trial of CYT-108 for osteoarthritis reports no adverse events among patients, with 14 out of 22 receiving the maximum of two doses. …See details»
Technology - Cytonics Corporation
We have contracted a research organization, Goodwin Biotechnology, to purify industrial-scale quantities of CYT-108 for pre-clinical experiments and FDA clinical trials. Keys to Success. …See details»
cytonics.com Reviews: Is this site a scam or legit?
This term indicates whether cytonics.com has landed on any online directories' blacklists and earned a suspicious tag. Assessing HTTPS Connectivity. This section provides insight into …See details»
Cytonics Videos - Cytonics Corporation
Cytonics has received over $25M in funding to date, including $1.8M from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). Now, we are …See details»